UroGen Pharma’s fair value estimate holds at US$35.63, with recent model tweaks leaving the price target itself unchanged. Analysts are using recent moves in other healthcare names, where cost ...
This is a course on the intermediate level for international students. The subject builds on skills and knowledge acquired in NORINT0110 or the equivalent. The classes strongly emphasize the students’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results